Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Lilly/Boehringer's refiled empagliflozin could launch in August

18.06.2014 / Scripintelligence

They say the product should gain approval to treat type 2 diabetes on 15 August, based on a two-month Class 1 resubmission (which would give a PDUFA date of 17 August, a Sunday, meaning approval would be likely on the Friday before).

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: